Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Rapid diagnostic kits drive Lumos revenue as FDA approval beckons for COVID tests
    • News

    Rapid diagnostic kits drive Lumos revenue as FDA approval beckons for COVID tests

    Lumos Diagnostics’ (ASX: LDX) vision for decentralised diagnostic testing is slowly coming together with the Company releasing their full year results just one month after debuting on the ASX. Across the business, revenue increased 198% from FY20 to $25 million with its Commercial Services division the real MVP, delivering $22.7 million in revenue, a 188%

    Read More
    Public
  • Healthia ascends as Australia’s fastest growing allied health provider
    • News

    Healthia ascends as Australia’s fastest growing allied health provider

    Increased attention to our health and wellbeing is driving the growth of healthcare company Healthia (ASX: HLA) which is realising commercial synergies between its podiatry, physiotherapy and optometry divisions to report a 52% increase in revenue to $140.4 million. Of particular interest to investors will be the fact that 9.1% of that was attributed to

    Read More
    Public
  • Regional expansion strategy paying dividends as Apiam profits jump again
    • News

    Regional expansion strategy paying dividends as Apiam profits jump again

    Continued expansion of Australia’s population beyond capital cities is seeing an influx of residents and jobs in regional towns which has resulted in veterinary clinic operator Apiam Animal Health (ASX: AHX) delivering a 24% jump in profit, capitalising on pet ownership and dairy industry trends. For FY21, Apiam has reported revenue of $126.2 million which

    Read More
    Public
  • Online shopping and home office upgrades send Harris Technology profits soaring 73%
    • News

    Online shopping and home office upgrades send Harris Technology profits soaring 73%

    It’s remarkable to think that a profitable eCommerce stock would be trading on the ASX at less than 1x revenue but that’s the case for undervalued retailer Harris Technology (ASX: HT8) which has reported a 73% jump in profit. The bumper result comes alongside a 206% increase in revenue to $41.8 million compared to last

    Read More
    Public
  • Rhinomed puts new child-friendly COVID swab to the test
    • News

    Rhinomed puts new child-friendly COVID swab to the test

    Unless you’ve been living under a rock- we’re in a global pandemic. By now, you’ve probably had the pleasure of having your brain tickled through your nose via nasal swab, fretting that your annual winter cold is actually the plague.  Whilst most of us can handle the violation that is a nasal swab, testing children

    Read More
    Public
  • Bitcoin Update – the Halving, ASIC & Transaction statistics
    • Opinion

    Bitcoin Update – the Halving, ASIC & Transaction statistics

    This is just a quick refresh on the operations of the Bitcoin (BTC) blockchain. BTC commenced in 2009 with an original 10,500,000 Bitcoins mined. The maximum total BTCs to be issued is 21,000,000. Miners are rewarded for each Block they successfully mine, currently they are receiving 6.25 BTC as a reward. After every 210,000 Blocks

    Read More
    Public
  • «
  • ‹
  • 466
  • 467
  • 468
  • 469
  • 470
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.